Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 15Recruiting 5Unknown 3Not yet recruiting 3Active not recruiting 3Terminated 1Suspended 1

Sponsor Class

OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Breast 6Thoracic 3Gynecologic 3Gastrointestinal 3Tumor-Agnostic 1Other 1Head & Neck 1Dermatologic 1

Conditions

Carcinoma, Non-Small-Cell Lung 2Neoplasms 1Melanoma 1Lung Neoplasms 1

Interventions

Carboplatin 132Cisplatin 129Pemetrexed 114Docetaxel 81Drug Therapy 62Gefitinib 57anlotinib 55Gemcitabine 55Erlotinib Hydrochloride 55Radiotherapy 48Bevacizumab 48pembrolizumab 47Paclitaxel 47Etoposide 44apatinib 42icotinib 41camrelizumab 39osimertinib 36Nivolumab 33Vinorelbine 31Radiosurgery 30sintilimab 29durvalumab 25aumolertinib 25endostar protein 24atezolizumab 22Endostatins 22toripalimab 19Blood Specimen Collection 19tislelizumab 18

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × Methods × Thoracic × Clear all
NCT04193956 2024-05-03

POINTING

University Medical Center Groningen

Unknown
3,500 enrolled
DermatologicThoracic

Carcinoma, Non-Small-Cell Lung, Melanoma

NCT03594682 2018-07-20

Optimizing the Therapeutic Dose of Apatinib Mesylate Tablets in Patients With Lung Cancer by Dose Titration:A Real World Exploratory Study

Beijing Chest Hospital

Phase NA Unknown
31 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT01213745 2010-10-21

The Use of a Quality of Life Questionnaire in Patients With Lung Cancer

Royal Marsden NHS Foundation Trust

Phase NA Unknown
138 enrolled
Thoracic

Lung Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡